Translate this page into:
Risk factors for postoperative complications of orthopedic surgery in patients with hemophilia: Second report
⁎Corresponding author: Jun Hirose. hirosej-ort@h.u-tokyo.ac.jp
-
Received: ,
Accepted: ,
This article was originally published by Reed Elsevier India Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.
Abstract
Abstract
This study was conducted to investigate the incidence in patients with hemophilia of postoperative complications and risk factors for these complications. Overall, 12 (6.5%) patients developed a postoperative infection. There were 6 (3.4%) postoperative surgical site infections. The presence of an inhibitor was the only risk factor for surgical site infection. Risk factors for delayed wound healing were older age, higher preoperative serum albumin level and procedures other than joint replacement or arthroscopy. HIV infection status was not a risk factor for postoperative complications.
Keywords
Hemophilic arthropathy
Orthopedic surgery
Complication
Surgical site infection
Risk factor
HIV infection
1 Introduction
Intra-articular hemorrhage is one of the major symptoms in patients with hemophilia (PWH). Recurrent bleeding in joints leads to degradation of cartilage and destruction of the joint structure, a condition called hemophilic arthropathy 1,2. Pain and limited motion of involved joints impair activities of daily living and quality of life. Because the effects of conservative treatment such as bracing or rehabilitation are limited, orthopedic surgery is generally recommended for severely destroyed joints 3. The development of factor concentrates has made it possible to perform orthopedic surgery safely for PWH. However, operations for hemophilic arthropathy are still challenging because of joint fibrosis, extremely limited range of motion and poor bone quality.
Several studies have reported that prolonged operative time, bleeding and blood-borne viral infections are associated with a higher incidence of complications in PWH, such as surgical site infection and delayed wound healing 4,5. Currently, there are few reports on complication rates and risk factors for complications following orthopedic surgery in PWH. Moreover, there is controversy about the influence of human immunodeficiency virus (HIV) infection status on the risk for surgical site infection. Several studies have suggested that patients who carry HIV have a higher postoperative infection rate than those without HIV 6–8, but others have reported infection rates associated with HIV positivity similar to those in the general population 9–12.
Previously, we investigated the risks associated with elective orthopedic surgery for PWH and found that HIV positivity was not a risk factor for perioperative complications. The only risk factor for infection we identified in that study was the presence of inhibitor of the factor concentrate 13. However, that study included a relatively small number of patients, and only univariate analysis was performed. The aim of the present study was to investigate the incidence of postoperative complications and preoperative risk factors for those complications based on a larger number of cases and using multivariate analysis. Additionally, we investigated whether HIV status influences the rate of postoperative complications in PWH. Clarifying such risk factors will aid in the decision for or against surgery and appropriately inform patients of the risks if an operation is contemplated.
2 Materials and methods
2.1 Patients
From 2006 to 2015, we performed 184 major orthopedic surgeries for 100 patients with hemophilia and other coagulation disorders in the Institute of Medical Science Research Hospital. We retrospectively reviewed the clinical characteristics and outcome of these patients to identify risk factors associated with postoperative complications. Data collected from the medical records included age; diagnosis; type of operation; viral infection status (i.e. HIV, hepatitis B [HBV] and hepatitis C [HCV]); Child classification; blood test results before surgery and postoperative complications, including surgical site infection, delayed wound healing and death within 6 months postoperatively.
2.2 Procedures and perioperative hemostasis
All operations were performed by the same surgical team. For patients without inhibitors, factor VIII or IX replacement therapy was administered with boluses and continuous infusion according to the department protocol. Preoperatively, patients were given a bolus dose of clotting factor aiming for a factor level of 100%, followed by a continuous infusion of factor concentrate to maintain the level at 100% for a several days, depending on the type of surgery. For patients with an inhibitor, a bypassing agent was used, either recombinant activated factor VII (rFVIIa, NovoSeven) or activated recombinant factor concentrate (FEIBA, Baxter). All operations were performed under general anesthesia. No antithrombotic prophylaxis was used.
The diagnosis of surgical site infection was based on the definition in the 1999 guidelines for the prevention of surgical site infection 14. Delayed wound healing was defined as a case in which sutures were left in place for longer than 2 weeks or where the wound required resuturing.
2.3 Statistical analysis
The association of individual risk factors with postoperative complications was determined using univariate and multivariate analysis. Univariate analysis was performed using Fisher’s exact test for categorical variables and Student’s t-test for continuous variables. Patient variables included in the analysis were age, diagnosis, viral infection status, type of surgery, presence of inhibitor, Child classification, preoperative laboratory values and pre-operative infection. Multivariate analysis was performed using logistic regression including the presence of HIV (fixed) and covariates selected by the backward elimination method. Covariates for multivariate analysis included age, type of hemophilia, type of surgery, preoperative laboratory values (white blood cell count, hemoglobin, platelet count, alanine aminotransferase, alkaline phosphatase, total protein, albumin, presence of an inhibitor, HBV surface antigen and HCV RNA) and preoperative infection. Some measurements were not included due to multicollinearity, missing values or lack of importance. Backward elimination was applied with the criterion to exclude with P > 0.05 until at least three variables remained, considering adjustment for confounding with the small number of the events. In addition, patients who were HCV-negative and those who underwent an arthroscopic procedure were excluded from multivariate analysis because none had a new infection or delayed wound healing. Statistical significance was set at a p value of < 0.05. All statistical analyses were performed using SPSS (IBM).
3 Results
From June 2006 to July 2015, 184 procedures were performed in 100 patients in our institution. The patients’ characteristics are shown in Table 1. The average age was 41.0 ± 13.5 years at the time of the surgery. The type of hemophilia included hemophilia A in 142 (77%), Hemophilia B in 40 (21.7%), factor VII deficiency in 1 (0.5%) and von Willebrand disease in 1 (0.5%). The operations included 108 arthroplasties (20 total hip arthroplasties, 3 revisions of hip arthroplasty, 82 total knee arthroplasties, 2 total elbow arthroplasties, and 1 total ankle arthroplasty), 34 arthroscopic procedures and 42 other operations (e.g. removal of pseudo tumor, limb amputation). HBV, HCV and HIV infections were present in 4.3%, 84.8% and 26.1% of patients, respectively. The mean preoperative CD4 count in patients with HIV were 411.2 ± 212.4 (range, 43–979) cells/ mm3. The mean length of hospital stay was 47.2 ± 28.5 days. Four patients died within 6 months postoperatively. Causes of death included chronic liver disease (2), acute myelogenous leukemia (1) and suicide (1). Overall, 12 patients (6.5%) developed a postoperative infection. Excluding 10 operations in patients who already had pre-existing infections, 6 (3.4%) new postoperative surgical site infections occurred. Delayed wound healing occurred in 4 (2.2%) cases. On univariate analysis, only the presence of an inhibitor was a significant risk factor for a new infection (p = 0.024). No infections occurred in patients who were not HCV-positive or among those who underwent arthroscopic surgery. The risk of delayed wound healing was significantly higher in patients who underwent procedures other than arthroscopy or arthroplasty (p = 0.002), patients with pre-existing infection (p = 0.003), those with a high preoperative total protein level (p = 0.001) and advanced age (p < 0.001). Death within 6 months was significantly associated with Child classification B or C, low preoperative white cell count, low preoperative hemoglobin, low preoperative platelet count, high preoperative aspartate aminotransferase, high preoperative alkaline phosphatase and low preoperative albumin level (Table 2).
| Surgical cases | ||
| Gender | male | 182 |
| female | 2 | |
| Age | years (range) | 41.0 (13-72) |
| Diagnosis | Haemophilia A (%) | 142 (77.2) |
| Haemophilia B (%) | 40 (21.7) | |
| FVII deficiency (%) | 1 (0.5) | |
| von Willebrand disease | 1 (0.5) | |
| Surgery | THA or re-THA | 23 |
| TKA or re-TKA | 82 | |
| TEA | 2 | |
| TAA | 1 | |
| AS | 34 | |
| others | 42 | |
| Inhibitor | negative (%) | 162 (88.0) |
| positive (%) | 22 (12.0) | |
| Viral infection | HCV negative/HIV negative (%) | 27 (14.7) |
| HCV positive/HIV negative (%) | 109 (59.2) | |
| HCV negative/HIV positive (%) | 1 (0.5) | |
| HCV positive/HIV positive (%) | 47 (25.5) | |
| Pre-existing infection | negative (%) | 174 (94.6) |
| positive (%) | 10 (5.4) |
| New infection | |||||||||
| Factor | Total | Absent | Present | p value | |||||
| HBs infection | negative | 166 | 161 | 97.0% | 5 | 3.0% | 0.249 | ||
| positive | 8 | 7 | 87.5% | 1 | 12.5% | ||||
| HCV infection | negative | 28 | 28 | 100.0% | 0 | 0.0% | 0.591 | ||
| positive | 146 | 140 | 95.9% | 6 | 4.1% | ||||
| HIV infection | negative | 129 | 124 | 96.1% | 5 | 3.9% | 1.000 | ||
| positive | 45 | 44 | 97.8% | 1 | 2.2% | ||||
| Type of procedure | arthroscopy | 34 | 34 | 100.0% | 0 | 0.0% | 0.704 | ||
| arthoplasty | 112 | 107 | 95.5% | 5 | 4.5% | ||||
| other | 28 | 27 | 96.4% | 1 | 3.6% | ||||
| Inhibitor | negative | 153 | 150 | 98.0% | 3 | 2.0% | 0.024 | ||
| positive | 21 | 18 | 85.7% | 3 | 14.3% | ||||
| Child classification | A | 102 | 96 | 94.1% | 6 | 5.9% | 1.000 | ||
| B or C | 10 | 10 | 100.0% | 0 | 0.0% | ||||
| Diagnosis (haemophilia A/B) | A | 117 | 112 | 95.7% | 5 | 4.3% | 1.000 | ||
| B | 27 | 26 | 96.3% | 1 | 3.7% | ||||
| Pre-existing infection | negative | ||||||||
| positive | |||||||||
| mean | SD | mean | SD | ||||||
| White blood cell | 174 | 168 | 5457.4 | 1773.3 | 6 | 5038.3 | 1266.8 | 0.568 | |
| Haemoglobin | 174 | 168 | 14.2 | 1.8 | 6 | 14.1 | 1.0 | 0.940 | |
| Platelet | 174 | 168 | 20.0 | 6.5 | 6 | 23.4 | 6.5 | 0.208 | |
| Aspartate transaminase | 174 | 168 | 30.7 | 20.7 | 6 | 28.8 | 15.5 | 0.825 | |
| Alanine transaminase | 174 | 168 | 32.4 | 25.4 | 6 | 24.7 | 21.5 | 0.465 | |
| Alkaline phosphatase | 174 | 168 | 310.8 | 110.7 | 6 | 244.5 | 70.5 | 0.148 | |
| Total protein | 172 | 166 | 7.3 | 0.5 | 6 | 7.7 | 0.5 | 0.057 | |
| Albumin | 171 | 165 | 4.3 | 0.5 | 6 | 4.5 | 0.3 | 0.360 | |
| CRP | 172 | 166 | 0.5 | 1.3 | 6 | 0.2 | 0.2 | 0.614 | |
| Age | 174 | 168 | 40.0 | 13.3 | 6 | 44.0 | 11.7 | 0.474 | |
| Albumin/Globrin ratio | 171 | 165 | 1.5 | 0.4 | 6 | 1.5 | 0.3 | 0.773 | |
| Delayed wound healing | |||||||||
| Factor | Total | Absent | Present | p value | |||||
| HBs infection | negative | 176 | 166 | 94.3% | 10 | 5.7% | |||
| positive | 8 | 8 | 100.0% | 0 | 0.0% | 1.000 | |||
| HCV infection | negative | 28 | 28 | 100.0% | 0 | 0.0% | |||
| positive | 156 | 146 | 93.6% | 10 | 6.4% | 0.364 | |||
| HIV infection | negative | 136 | 128 | 94.1% | 8 | 5.9% | |||
| positive | 48 | 46 | 95.8% | 2 | 4.2% | 1.000 | |||
| Type of procedure | arthroscopy | 34 | 34 | 100.0% | 0 | 0.0% | |||
| arthoplasty | 113 | 110 | 97.3% | 3 | 2.7% | ||||
| other | 37 | 30 | 81.1% | 7 | 18.9% | 0.002 | |||
| Inhibitor | negative | 162 | 152 | 93.8% | 10 | 6.2% | |||
| positive | 22 | 22 | 100.0% | 0 | 0.0% | 0.611 | |||
| Child classification | A | 108 | 100 | 92.6% | 8 | 7.4% | |||
| B or C | 12 | 11 | 91.7% | 1 | 8.3% | 1.000 | |||
| Diagnosis (haemophilia A/B) | A | 126 | 118 | 93.7% | 8 | 6.3% | |||
| B | 28 | 26 | 92.9% | 2 | 7.1% | 1.000 | |||
| Pre-existing infection | negative | 124 | 118 | 95.2% | 6 | 4.8% | |||
| positive | 10 | 6 | 60.0% | 4 | 40.0% | 0.003 | |||
| mean | SD | mean | SD | ||||||
| White blood cell | 184 | 174 | 5503.7 | 1808.9 | 10 | 5722.0 | 2012.6 | 0.713 | |
| Haemoglobin | 184 | 174 | 14.1 | 1.8 | 10 | 13.2 | 2.9 | 0.117 | |
| Platelet | 184 | 174 | 20.4 | 7.0 | 10 | 20.9 | 5.7 | 0.822 | |
| Aspartate transaminase | 184 | 174 | 30.5 | 20.9 | 10 | 28.5 | 13.8 | 0.762 | |
| Alanine transaminase | 184 | 174 | 31.8 | 25.4 | 10 | 20.9 | 14.0 | 0.182 | |
| Alkaline phosphatase | 184 | 174 | 309.6 | 111.2 | 10 | 351.8 | 89.1 | 0.241 | |
| Total protein | 182 | 172 | 7.3 | 0.5 | 10 | 7.8 | 0.3 | 0.001 | |
| Albumin | 181 | 171 | 4.3 | 0.5 | 10 | 4.4 | 0.5 | 0.413 | |
| CRP | 182 | 172 | 0.5 | 1.3 | 10 | 1.4 | 2.7 | 0.055 | |
| Age | 184 | 174 | 39.9 | 13.0 | 10 | 59.2 | 9.1 | <0.001 | |
| Albumin/Globrin ratio | 181 | 171 | 1.5 | 0.4 | 10 | 1.3 | 0.3 | 0.213 | |
| Death | |||||||||
| Factor | Total | Absent | Present | p value | |||||
| HBs infection | negative | 175 | 171 | 97.7% | 4 | 2.3% | |||
| positive | 8 | 8 | 100.0% | 0 | 0.0% | 1.000 | |||
| HCV infection | negative | 28 | 28 | 100.0% | 0 | 0.0% | |||
| positive | 155 | 151 | 97.4% | 4 | 2.6% | 1.000 | |||
| HIV infection | negative | 135 | 133 | 98.5% | 2 | 1.5% | |||
| positive | 48 | 46 | 95.8% | 2 | 4.2% | 0.282 | |||
| Type of procedure | arthroscopy | 34 | 33 | 97.1% | 1 | 2.9% | |||
| arthoplasty | 112 | 110 | 98.2% | 2 | 1.8% | ||||
| other | 37 | 36 | 97.3% | 1 | 2.7% | 0.813 | |||
| Inhibitor | negative | 161 | 157 | 97.5% | 4 | 2.5% | |||
| positive | 22 | 22 | 100.0% | 0 | 0.0% | 1.000 | |||
| Child classification | A | 108 | 108 | 100.0% | 0 | 0.0% | |||
| B or C | 12 | 10 | 83.3% | 2 | 16.7% | 0.009 | |||
| Diagnosis (haemophilia A/B) | A | 125 | 123 | 98.4% | 2 | 1.6% | |||
| B | 28 | 26 | 92.9% | 2 | 7.1% | 0.153 | |||
| Pre-existing infection | negative | 123 | 120 | 97.6% | 3 | 2.4% | |||
| positive | 10 | 10 | 100.0% | 0 | 0.0% | 1.000 | |||
| mean | SD | mean | SD | ||||||
| White blood cell | 183 | 179 | 5580.11 | 1783.50 | 4 | 2655.00 | 1047.04 | 0.001 | |
| Haemoglobin | 183 | 179 | 14.11 | 1.83 | 4 | 11.85 | 2.91 | 0.017 | |
| Platelet | 183 | 179 | 20.60 | 6.82 | 4 | 12.10 | 5.35 | 0.014 | |
| Aspartate transaminase | 183 | 179 | 29.97 | 20.01 | 4 | 52.25 | 35.98 | 0.032 | |
| Alanine transaminase | 183 | 179 | 31.29 | 25.32 | 4 | 28.50 | 13.03 | 0.827 | |
| Alkaline phosphatase | 183 | 179 | 305.55 | 100.14 | 4 | 602.50 | 180.38 | <0.001 | |
| Total protein | 181 | 177 | 7.31 | 0.49 | 4 | 6.88 | 0.59 | 0.081 | |
| Albumin | 180 | 176 | 4.29 | 0.48 | 4 | 3.55 | 0.94 | 0.003 | |
| CRP | 181 | 177 | 0.57 | 1.46 | 4 | 0.41 | 0.27 | 0.823 | |
| Age | 183 | 179 | 40.86 | 13.64 | 4 | 47.50 | 7.55 | 0.334 | |
| Albumin/Globrin ratio | 180 | 176 | 1.49 | 0.38 | 4 | 1.13 | 0.46 | 0.068 | |
On multivariate logistic analysis, the only independent risk factor for a new infection was the presence of inhibitor (odds ratio [OR], 23.2; 95% confidence interval [CI], 2.8–193.5; p = 0.004; Table 3), while risk factors for delayed wound healing were higher age (OR, 1.2; 95% CI, 1.1–1.3; p = 0.002), type of operation classified as ‘others’ (OR, 28.9; 95% CI, 3.8–222.4; p = 0.001) and high preoperative albumin (OR, 16.8; 95% CI, 1.9–151.1; p = 0.012). HIV infection was not a risk factor for any complication in this study population. An anti-FVIII inhibitor developed in 2 patients after total knee arthroplasty, 1 of whom had an inhibitor titer of 2 Bethesda units (BU) which disappeared after 9 months from the first detection and 1 who continued to have a titer of 1 BU. There were no thromboembolic events in this series.
| Risk for new infection | |||
| Odds ratio | 95% CI | Adjusted p value | |
| Inhibitor | 23.2 | [2.8-193.5] | 0.004 |
| Alkaline phosphatasea | 0.99 | [0.97-1.0] | 0.062 |
| Total proteina | 6.3 | [0.8-50.8] | 0.084 |
| HIV-positive | 0.7 | [0.1-6.7] | 0.939 |
| Risk for delayed wound healing | |||
| Odds ratio | 95% CI | Adjusted p value | |
| Agea | 1.2 | [1.1-1.3] | 0.002 |
| Type of procedure (others vs. arthroplasties) | 28.9 | [3.8-222.4] | 0.001 |
| Albumina | 16.8 | [1.9-151.1] | 0.012 |
| HIV-positive | 1.6 | [0.2-13.1] | 0.67 |
4 Discussion
The current study investigated the incidence of complications after orthopedic surgery in PWH and identified risk factors for these complications. We found that the incidence of infections for patients without pre-existing infections was 3.4%. The only significant risk factor for this complication was the presence of an inhibitor. HIV status was not significantly related to infections or delayed wound healing. Previous studies have shown that postoperative infection rates in PWH are much higher than patients without bleeding disorders 6,7,15. Kelly et al. reported no early infections but three (11%) late infections after hip arthroplasty in PWH 16. Rodriguez et al. reported that late infection is the main concern following total knee arthroplasty in PWH 17. The relatively low rate of infection in our study may have been due to the short observation period (6 months). A longer follow-up period might yield different results.
Both univariate and multivariate analysis revealed that the presence of an inhibitor was the only significant risk factor for infection, which confirmed our previous results of univariate analysis of data from a smaller number of subjects 13. Solimeno et al. reported that the presence of an inhibitor is the main risk factor for infection, having a high attributable risk. They speculated that prolonged operative time, bleeding and/or delayed wound healing may explain the higher infection rates in patients with inhibitors 18. In the present study, it was difficult to compare operative time in patients with or without inhibitors because we included a variety of surgical procedures which normally require varying lengths of time. The presence of an inhibitor in our patients was not significantly associated with delayed wound healing, suggesting that the higher incidence of infections in patients with an inhibitor may have been related to greater amounts of bleeding or perhaps prolonged operative time. Delayed wound healing was significantly associated on multivariate analysis with advanced age, operations other than arthroplasty or arthroscopy and a high preoperative albumin. It has been well documented that ageing adversely affects wound healing because of reduced inflammatory or proliferative response and fragility of the ageing skin 19,20. The ”other' category of operations included those for surgical site infection (e.g. debridement) and amputation, in which wound complications often occur because of vascular problem and reduced tissue viability. This may be why the 'other' category of procedures was a significant risk factors for delayed wound healing. The adverse effects of malnutrition on wound healing are well known and the serum albumin level is clinically useful parameter for patients' nutritional status. Many studies have demonstrated the adverse effect of low serum albumin on wound healing 21–23, which makes our finding of a high albumin level as a risk factor for poor healing surprising. The reason for this discrepancy, whether sample size or unknown confounders, is unclear.
In the present study, both univariate and multivariate analysis showed that HIV infection status was not associated with the incidence of complications. Ragni et al. reported a higher postoperative infection rate in HIV-positive patients with hemophilia whose CD4 counts were 200/mm3 or less than the rates of infection in the general population 7. Due to recent advances in HIV treatment and care, the immunologic outcome and life expectancy of patients infected with HIV have improved dramatically. In principle, we only perform elective surgery in patients with CD4 counts > 400 cells/mm3, so our results are not particularly surprising, given that the mean CD4 counts in our series was 411.2 cells/mm3. Optimal antiviral therapy and proper patient selection therefore are likely to reduce the risk of postoperative complications in patients who are HIV-positive.
The current study has several limitations. First, due to the very small number of the events (around 10 or less), it was difficult to assess outcome-related factors, despite statistical methods that included multivariate analysis. Second, the follow-up period after surgery was short at 6 months. Therefore, complications that might have occurred later, such as late infections, were undetected. Third, because the current study included various types of operations, it was difficult to compare complications among patients undergoing the same procedure. In spite of these limitations, the strength of our study is that all procedures were performed by the same surgical team with the same hemostatic protocols at a single institution.
In conclusion, the overall complication rate in our patients was low. The presence of an inhibitor was the only risk factor for surgical site infection, while higher age, higher preoperative serum albumin level and surgeries other than joint replacement or arthroscopy were risk factors for delayed wound healing. HIV infection status was not a risk factor for postoperative complications.
Contributions
J.H. and H.T. designed research, performed research, collected data and wrote the manuscript; M.N. performed statistical analyses of data; T.K. wrote and reviewed the manuscript. The authors stated that they had no interests which might be perceived as posing a conflict or bias.
All authors have approved the final version for submission.
Role of the funding source
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Conflict of interest
None.
References
- Hemophilic arthropathy. Current concepts of pathogenesis and management. J Bone Jt Surg Am Vol. 1977;59(3):287-305.
- [Google Scholar]
- Knee and hip arthroplasty infection rates in persons with haemophilia: a 27 year single center experience during the HIV epidemic. Haemophilia. 2005;11(3):233-239.
- [Google Scholar]
- Infected joint replacements in HIV-positive patients with haemophilia. J Bone Jt Surg Brit Vol. 2001;83(7):1050-1054.
- [Google Scholar]
- Postoperative infection following orthopaedic surgery in human immunodeficiency virus-infected hemophiliacs with CD4 counts < or = 200/mm3. J Arthroplasty. 1995;10(6):716-721.
- [Google Scholar]
- Thromboprophylaxis and incidence of venous thromboembolism in patients with hemophilia A or B who underwent high-risk orthopedic surgeries. Clin Appl Thrombosis/Hemostasis. 2016;22(2):161-165.
- [Google Scholar]
- Synovectomy or total replacement of the knee in hemophilia. J Bone Jt Surg Am Vol. 1979;61(1):69-75.
- [Google Scholar]
- Total knee arthroplasty in hemophilic arthropathy. J Bone Jt Surg Am Vol. 2002;84-A(7):1138-1141.
- [Google Scholar]
- Venous thrombosis prophylaxis in haemophilics undergoing major orthopaedic surgery: a survey of haemophilia treatment centres. Haemophilia. 2009;15(6):1337-1338.
- [Google Scholar]
- Total knee arthroplasty in HIV-positive haemophilic patients. Haemophilia. 2002;8(3):387-392.
- [Google Scholar]
- The risk of elective orthopaedic surgery for haemophilia patients: Japanese single-centre experience. Haemophilia. 2013;19(6):951-955.
- [Google Scholar]
- Guideline for prevention of surgical site infection, 1999. Centers for disease control and prevention (CDC) Hospital infection control practices advisory committee. Am J Infect Control. 1999;27(2):97-132.
- [Google Scholar]
- Knee arthroplasty in hemophilic arthropathy. Clin Orthop Relat Res. 1999;360:169-173.
- [Google Scholar]
- Hip arthroplasty in hemophilic arthropathy. J Bone Jt Surg Am Vol. 1995;77(6):828-834.
- [Google Scholar]
- Infection after total knee arthroplasty in haemophilic arthropathy with special emphasis on late infection. Haemophilia. 2011;17(5):e831-832.
- [Google Scholar]
- Factors influencing the long-term outcome of primary total knee replacement in haemophiliacs: a review of 116 procedures at a single institution. Br J Haematol. 2009;145(2):227-234.
- [Google Scholar]
- Nutritional status: importance in predicting wound-healing after amputation. J Bone Jt Surg Am Vol. 1984;66(1):71-75.
- [Google Scholar]
- Nutritional status and wound healing in lower extremity amputations. Clin Orthop Relat Res. 1987;217:253-256.
- [Google Scholar]
- Predictors of delayed wound healing after endovascular therapy of isolated infrapopliteal lesions underlying critical limb ischemia in patients with high prevalence of diabetes mellitus and hemodialysis. Eur J Vasc Endovasc. 2015;49(5):565-573.
- [Google Scholar]
